arrow
M

Marceline Côté

University of Ottawa
H指数:26
被引数:2,963

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of oseltamivir-resistant A(H5N1) clade 2.3.4.4b, genotype D1.1 variants identified in poultry farms of British Columbia, Canada

加拿大不列颠哥伦比亚省禽类农场中分离的奥司他韦耐药A(H5N1) 2.3.4.4b亚群D1.1基因型变异体的表征

2026-07-080
OA
Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants

VE607优化以生成对SARS-CoV-2变体具有增强中和活性的类似物

2025-10-010
PRE
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
2023-01-0117
OAAI
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
2022-10-0110
OAAI
Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2

温度影响来自Omicron亚变体的SARS-CoV-2尖峰与人类ACE2之间的相互作用

2022-09-3010
OAAI
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen

在生物反应器药物筛选后鉴定FDA批准的联苯苄唑作为SARS-CoV-2阻断剂

2022-09-016
OAAI
Regional connectivity drove bidirectional transmission of SARS-CoV-2 in the Middle East during travel restrictions
2022-08-157
OAAI
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
2022-03-0141
OAAI
Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes
2022-01-147
OAAI
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern

两种广泛中和抗体针对SARS-CoV-2令人关注的新兴变体的结构基础和作用方式

2022-01-0188
OAAI